IP Talk with Wolf Greenfield Wolf Greenfield

John Harmon is a shareholder in both the Mechanical and Chemical & Materials Technologies Practices at Wolf Greenfield. He represents clients in industry and academia in a wide range of technologies related to the mechanical, materials, and chemistry fields. One area of particular interest these days is the evolving impact of artificial intelligence (AI) on intellectual property matters. The United States Patent and Trademark Office (USPTO) recently issued its “Inventorship Gui...

Rob Sahr is a shareholder in Wolf Greenfield’s Biotechnology Practice. He develops strategies for life science companies to maximize exclusivity for therapeutic and diagnostic products. Rob has also assisted federal grant recipients and contractors with Bayh-Dole compliance.Originally passed at the end of 1980, the Bayh–Dole Act permits ownership by contractors of inventions arising from federal government-funded research. In recent months, the Biden Administration has seemed intent on more a...

Scott McKeown is a shareholder in Wolf Greenfield’s Post-Grant Proceedings Practice. Based in the firm’s Washington, DC office, Scott focuses his practice on high-stakes matters before the US Patent Trial & Appeal Board, Court of Appeals for the Federal Circuit, and related patent litigation matters. Recognized as one of the top PTAB trial attorneys in the US, Scott is also a frequent speaker and author on various intellectual property topics and his award-winning blog can be followed at ...

We’re pleased to feature May Rohrbach in this episode of Wolf Greenfield’s Alumni Spotlight series. May was previously a patent agent in Wolf Greenfield’s Electrical & Computer Technologies Practice. She was also part of the firm’s technology specialist intern program. Now, May serves as a QA Engineer II at Blink, an Amazon Company. Blink delivers affordable, innovative, and easy-to-use smart home security devices.Here are some highlights from May’s turn in the Alumni Spotlight on IP...

2024 is upon us and it’s going to be another busy year for intellectual property law. In this episode of IP Talk with Wolf Greenfield, you’ll hear Wolf Greenfield attorneys from a variety of practice areas offering their insights on what to expect in the months ahead. Here are some of the highlights.01:06 - Jeff Hsi commented on the impact the Amgen v. Sanofi decision may have on the biotech and pharmaceutical industries in 2024. 01:59 - Jonathan Roses with thoughts on the In re Cellect ...

Libbie DiMarco is a shareholder at Wolf Greenfield and, along with Dan Young, co-chair of the firm's Washington, DC office. Libbie is an intellectual property litigator focusing her practice primarily on complex patent litigation in Federal District Court and before the US International Trade Commission (ITC). In this episode of IP Talk with Wolf Greenfield, Libbie highlights the impressive growth already taking place in the DC office and looks ahead to 2024. Here are the highlights.01:0...